LRRC8 complexes are ATP release channels regulating platelet activation and arterial thrombosis.
| Publication Type | Academic Article |
| Authors | Tranter J, Mikami R, Kumar A, Brown G, Abd El-Aziz T, Zhao Y, Arullampalam P, Ashworth K, Jha V, Abraham N, Meyer C, Ajanel Gomez A, Xie L, Feng Y, Hong J, Zhang H, Kumari T, Balutowski A, Liu A, Bark D, Nair V, Lasky N, Stitziel N, Lerner D, Campbell R, Di Paola J, Cho J, Sah R |
| Journal | Blood |
| Date Published | 06/20/2025 |
| ISSN | 1528-0020 |
| Abstract | Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in Leucine-Rich Repeat Containing 8 (LRRC8) protein subunits that form the Volume-Regulated Anion Channel (VRAC) which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume, adhesion, and agonist-stimulated activation, aggregation, ATP secretion and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser-injury induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without affecting bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium-PI3K-AKT signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets which positively regulates platelet function and thrombosis, providing a proof-of-concept for a novel anti-thrombotic drug target. |
| DOI | 10.1182/blood.2024026667 |
| PubMed ID | 40540747 |